Recent News

Share
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
541 News Items found
In the Clinic
MSK molecular imaging specialist Jan Grimm
New Imaging Technique Could Improve Cancer Screening and Diagnosis in Developing Countries and Rural Areas

A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.
An illustration of a fish fin touching a human finger
Hands, Feet, and Fins: The Connection That Explains Acral Melanoma

Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.
Dirk Remus and Richard Hite
SKI Scientists Determine Structure of a DNA Damage 'First Responder'

The results of this collaborative project overturn some conventional wisdom about how the DNA repair process works.
A colorful pigeon standing in an urban setting.
SKI Scientists Discover a New Twist on an 80-Year-Old Biochemical Pathway

With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.
Memorial Sloan Kettering MERIT Sawyers Fellowship recipient Chris Bourne
A Young Scientist Earns MSK Fellowship: Here’s When He Had His ‘Aha’ Moment

Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.
colorful picture of cancer cells
The Mystery of Metastasis: Can a Tumor’s Genetic Mutations Predict Whether and Where Cancer Will Spread?

Data from 25,000 patients is helping scientists answer this and many other important questions.
Lab worker dressed in “bunny suit” working with machine.
A New Immunotherapy Discovery: Putting a HIT on Elusive Cancer Cells

A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.
In the Lab
Luis Parada in his lab
Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key

In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors.
Feature
Separate headshots of three researchers — Diana Mandelker, Jorge Reis-Filho, and Fresia Pareja
How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk

MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations.
SKI scientists David Scheinberg and Derek Tan
Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs

These souped-up versions may help overcome some limitations of existing CAR T cells.